Spinocerebellar ataxia type 6 family with phenotypic overlap with Multiple System Atrophy

Rana Hanna Al-Shaikh1, Anna I Wernick1, Audrey J Strongosky1

  • 1Mayo Clinic, Jacksonville, Florida, United States.

Abstract

Insights

Multiple system atrophy (MSA) and spinocerebellar ataxia (SCA) present similar symptoms. Genetic analysis revealed a rare familial MSA case was actually spinocerebellar ataxia type 6 (SCA6), highlighting diagnostic challenges.

Area of Science:

  • Neurodegenerative diseases
  • Genetics
  • Neurology

Background:

  • Multiple system atrophy (MSA) and spinocerebellar ataxia (SCA) are progressive neurodegenerative disorders.
  • These conditions often present with overlapping clinical symptoms, complicating differential diagnosis.

Observation:

  • A familial case initially suspected as MSA exhibited symptoms including imbalance, falls, weakness, and autonomic dysfunction.
  • Genetic analysis of the affected individual identified mutations in the CACNA1A gene, consistent with SCA6.

Findings:

  • A rare familial case diagnosed as MSA was reclassified as spinocerebellar ataxia type 6 (SCA6) based on genetic testing.
  • Genetic screening of 80 MSA patients identified one familial case with SCA6; the remaining 79 were negative for SCA6.

Implications:

  • The similar early presentations of MSA and SCA can create diagnostic dilemmas.
  • Further research is needed to develop biomarkers for distinguishing between MSA and SCA, improving patient management.

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.5K